These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35867500)

  • 61. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
    Ferrante ND; Lo Re V
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.
    Goossens N; de Vito C; Mangia A; Clément S; Cenderello G; Barrera F; D'Ambrosio R; Coppola N; Zampino R; Stanzione M; Adinolfi LE; Wedemeyer H; Semmo N; Müllhaupt B; Semela D; Malinverni R; Moradpour D; Heim M; Trincucci G; Rubbia-Brandt L; Negro F;
    J Viral Hepat; 2018 Aug; 25(8):920-929. PubMed ID: 29532619
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment.
    Trigo C; do Brasil PE; Costa MJ; de Castro L
    J Viral Hepat; 2016 Dec; 23(12):1027-1035. PubMed ID: 27624908
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.
    Saravanan S; Madhavan V; Velu V; Murugavel KG; Waldrop G; Solomon SS; Balakrishnan P; Kumarasamy N; Smith DM; Mayer KH; Solomon S; Thyagarajan SP
    J Int Assoc Provid AIDS Care; 2014; 13(1):85-90. PubMed ID: 23722085
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
    PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Screening for acquired latent tuberculosis in rheumatoid arthritis patients on tumor necrosis factor inhibition therapy in Southern California.
    Goel N; Torralba K; Downey C; Salto L
    Clin Rheumatol; 2020 Aug; 39(8):2291-2297. PubMed ID: 32112272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes.
    Peebles K; Nchimba L; Chilengi R; Bolton Moore C; Mubiana-Mbewe M; Vinikoor MJ
    J Trop Pediatr; 2015 Dec; 61(6):464-7. PubMed ID: 26338421
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
    Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    Chambal LM; Gudo ES; Carimo A; Corte Real R; Mabunda N; Maueia C; Vubil A; Zicai AF; Bhatt N; Antunes F
    PLoS One; 2017; 12(7):e0181836. PubMed ID: 28759595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey.
    Ioannou GN
    Ann Intern Med; 2011 Mar; 154(5):319-28. PubMed ID: 21357909
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.
    Bennett DE; Courval JM; Onorato I; Agerton T; Gibson JD; Lambert L; McQuillan GM; Lewis B; Navin TR; Castro KG
    Am J Respir Crit Care Med; 2008 Feb; 177(3):348-55. PubMed ID: 17989346
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of occult hepatitis B virus infection among subjects with isolated hepatitis B core antibodies: Results from a 3-year survey in an Italian tertiary-care hospital.
    De Conto F; Buttrini M; Dell'Anna ML; Maccari C; Montanari G; Arcangeletti MC; Martinelli M; Chezzi C; Calderaro A
    Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101892. PubMed ID: 35202845
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The prevalence of hepatitis B virus infection markers and socio-demographic risk factors in HIV-infected patients in Southern Brazil.
    Martins S; Livramento Ad; Andrigueti M; Kretzer IF; Machado MJ; Spada C; Treitinger A
    Rev Soc Bras Med Trop; 2014; 47(5):552-8. PubMed ID: 25467254
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence and determinants of latent tuberculosis infection among frontline tuberculosis healthcare workers in southeastern China: A multilevel analysis by individuals and health facilities.
    Chen B; Gu H; Wang X; Wang F; Peng Y; Ge E; Upshur R; Dai R; Wei X; Jiang J
    Int J Infect Dis; 2019 Feb; 79():26-33. PubMed ID: 30471404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada.
    Binka M; Butt ZA; McKee G; Darvishian M; Cook D; Wong S; Yu A; Alvarez M; Samji H; Wong J; Krajden M; Janjua NZ
    Int J Infect Dis; 2021 May; 106():246-253. PubMed ID: 33771673
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study.
    Trollfors B; Sigurdsson V; Dahlgren-Aronsson A
    Int J Infect Dis; 2021 Aug; 109():279-282. PubMed ID: 34174429
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
    Firnhaber C; Chen CY; Evans D; Maskew M; Schulz D; Reyneke A; Kramvis A
    Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
    Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
    World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.